Avadel Pharma Earnings, Revenue beat In Q2

  • Investing.com
Avadel Pharma Earnings, Revenue beat In Q2

Investing.com - Avadel Pharma reported second quarter earnings that beat analysts' expectations on Monday and revenue that topped forecasts.

The firm reported earnings per share of $0.49 on revenue of $10.09M. Analysts polled by Investing.com expected EPS of $-0.17 on revenue of $8.23M. .

Avadel Pharma shares lost 1.32% to trade at $8.25 in pre-market trade following the report.

For the year, Avadel Pharma shares are up 10.73%, under-performing the Nasdaq which is up 22.72% year to date.

Avadel Pharma follows other major Healthcare sector earnings this month


On Thursday, July 16, 2020, J&J reported second quarter EPS of $1.67 on revenue of $18.34B, compared to forecasts of EPS of $1.49 on revenue of $17.61B.

Roche Holding ADR earnings beat analyst's expectations on Thursday, July 23, 2020, with second quarter EPS of $1.45 on revenue of $15.27B. Investing.com analysts expected EPS of $1.42 on revenue of $15.43B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100